443 related articles for article (PubMed ID: 30268486)
1. Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer.
Ilie M; Beaulande M; Hamila M; Erb G; Hofman V; Hofman P
Lung Cancer; 2018 Oct; 124():90-94. PubMed ID: 30268486
[TBL] [Abstract][Full Text] [Related]
2. Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Roberts EA; Morrison LE; Behman LJ; Draganova-Tacheva R; O'Neill R; Solomides CC
Ann Diagn Pathol; 2020 Apr; 45():151454. PubMed ID: 31923744
[TBL] [Abstract][Full Text] [Related]
3. p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) category.
Walia R; Jain D; Madan K; Sharma MC; Mathur SR; Mohan A; Iyer VK; Kumar L
Indian J Med Res; 2017 Jul; 146(1):42-48. PubMed ID: 29168459
[TBL] [Abstract][Full Text] [Related]
4. Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer.
Ilié M; Beaulande M; Long-Mira E; Bontoux C; Zahaf K; Lalvée S; Hamila M; Benzaquen J; Cohen C; Berthet JP; Marquette CH; Lassalle S; Hofman V; Hofman P
Lung Cancer; 2022 Apr; 166():1-8. PubMed ID: 35134710
[TBL] [Abstract][Full Text] [Related]
5. Non-Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non-Small-cell Lung Cancer Favor Adenocarcinoma.
Shiran I; Heller E; Jessel S; Kamer I; Daniel-Meshulam I; Navon R; Urban D; Onn A; Bar J
Clin Lung Cancer; 2017 May; 18(3):316-323.e1. PubMed ID: 28237243
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non-Small-Cell Lung Cancer.
McLaughlin J; Han G; Schalper KA; Carvajal-Hausdorf D; Pelekanou V; Rehman J; Velcheti V; Herbst R; LoRusso P; Rimm DL
JAMA Oncol; 2016 Jan; 2(1):46-54. PubMed ID: 26562159
[TBL] [Abstract][Full Text] [Related]
7. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
[TBL] [Abstract][Full Text] [Related]
8. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
9. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.
Warth A; Muley T; Herpel E; Meister M; Herth FJ; Schirmacher P; Weichert W; Hoffmann H; Schnabel PA
Histopathology; 2012 Dec; 61(6):1017-25. PubMed ID: 22882703
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 testing of non-small cell lung cancer using different antibodies and platforms: a Swiss cross-validation study.
Savic S; Berezowska S; Eppenberger-Castori S; Cathomas G; Diebold J; Fleischmann A; Jochum W; Komminoth P; McKee T; Letovanec I; Jasarevic Z; Rössle M; Singer G; von Gunten M; Zettl A; Zweifel R; Soltermann A; Bubendorf L
Virchows Arch; 2019 Jul; 475(1):67-76. PubMed ID: 31127385
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
Zachara-Szczakowski S; Verdun T; Churg A
Hum Pathol; 2015 May; 46(5):776-82. PubMed ID: 25776027
[TBL] [Abstract][Full Text] [Related]
12. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S
Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101
[TBL] [Abstract][Full Text] [Related]
13. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
14. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of cytology in sub typing non small cell lung carcinomas.
Patel TS; Shah MG; Gandhi JS; Patel P
Diagn Cytopathol; 2017 Jul; 45(7):598-603. PubMed ID: 28429425
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of fine needle aspiration cytology and core biopsy histopathology with or without immunohistochemical staining in the subtyping of the non-small cell lung carcinomas: Experience from an academic centre in Turkey.
Bayrak BY; Paksoy N; Vural Ç
Cytopathology; 2021 May; 32(3):331-337. PubMed ID: 33145811
[TBL] [Abstract][Full Text] [Related]
17. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM
J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168
[TBL] [Abstract][Full Text] [Related]
18. Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer.
Wang H; Agulnik J; Kasymjanova G; Wang A; Jiménez P; Cohen V; Small D; Pepe C; Sakr L; Fiset PO; Auger M; Camilleri-Broet S; Alam El Din M; Chong G; van Kempen L; Spatz A
Ann Oncol; 2018 Jun; 29(6):1417-1422. PubMed ID: 29659668
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].
Warth A
Pathologe; 2015 Nov; 36 Suppl 2():194-200. PubMed ID: 26391251
[TBL] [Abstract][Full Text] [Related]
20. [Predictive PD-L1 immunohistochemistry for non-small cell lung cancer : Current state of the art and experiences of the first German harmonization study].
Scheel AH; Dietel M; Heukamp LC; Jöhrens K; Kirchner T; Reu S; Rüschoff J; Schildhaus HU; Schirmacher P; Tiemann M; Warth A; Weichert W; Fischer RN; Wolf J; Büttner R
Pathologe; 2016 Nov; 37(6):557-567. PubMed ID: 27510417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
